Menu Search
Equities

EMV Capital PLC

NTK1:FRA

EMV Capital PLC

Actions
  • Price (EUR)0.488
  • Today's Change-0.017 / -3.37%
  • Shares traded--
  • 1 Year change-22.54%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EMV Capital plc, formerly NetScientific plc, is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. It develops customized, proactive investment strategies for its subsidiaries and portfolio companies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., and ProAxsis Limited, among others.

  • Revenue in GBP (TTM)1.81m
  • Net income in GBP-2.97m
  • Incorporated2012
  • Employees29.00
  • Location
    EMV Capital PLC20 St Andrew StreetLONDON EC4A 3AGUnited KingdomGBR
  • Phone+44 203 011 2234
  • Websitehttps://emvcapital.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.